Your best source on science and technology news from Connecticut

Provided by AGP

STEM Times of Connecticut: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times of Connecticut.

Press releases published on May 4, 2026

Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering
Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion
Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the…
What is the best internet solution for business travel? Why Holafly for Business is becoming the preferred choice for global companies
Virtune AB (Publ) („Virtune“) hat die monatliche Neugewichtung für April 2026 des Virtune Crypto Altcoin Index ETPs durchgeführt
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for April 2026 of its Virtune Crypto Altcoin Index ETP
Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för april 2026 av Virtune Crypto Altcoin Index ETP
Proper Hills Launches Ultra-Slim Alloy Magnetic Power Bank for Design-Conscious Consumers
Unbounded Vision: Dreame Window Cleaning Robot Debuts in North America, Redefining Vertical Cleaning with Precision Technology
LakeFusion Raises $7.5M Seed Financing to Redefine Master Data Management (MDM) Natively on Databricks
Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
ノベルティ・ノビリティ、AGCバイオロジクスと提携し、二重特異性抗体候補薬の開発を推進
노벨티 노빌리티 (Novelty Nobility), 이중특이성 항체 개발 위해 AGC Biologics와 협력 확대

Share us

on your social networks:

Sign up for:

STEM Times of Connecticut

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.